Avsar.
BA

Healthcare · Pharmaceuticals

Bajaj Healthcare Ltd (BAJAJHCARE)

₹358.05

Mkt cap
₹1,113 Cr
P/E ratio
19.80
P/B
2.27
Div yield
0.45%
ROE
8.26%
ROCE
11.50%
EPS (TTM)
₹18.08
Book value
₹158
52W range
272–516
Sector
Healthcare

Price history

Previous close

Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations [1]

NSE BAJAJHCAREBSE 539872
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−30.60% from high
₹358
₹272+31.47% from low₹516
Current
₹358.05
Prev close
₹352.55
Day
+1.56%
Price performance
1D
+1.56%
1W
+9.05%
1M
+11.86%
3M
+17.76%
6M
+14.41%
1Y
−17.39%
YTD
−14.46%

Financials

Revenue, profit & margin
P/E ratio
19.8×
BAJAJHCARE is 43% below the sector median of 34.6×
BAJAJHCARE19.8×
Sector median34.6×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales130101109134132133123154149148161153166
Expenses1088289118108109101143124121131130137
Operating Profit22192016242522122527312329
OPM %17%19%18%12%19%18%18%8%16%18%19%15%17%
Other Income-55-7-7-36-04-113101-341
Interest9876886656666
Depreciation6777777867787
Profit before tax-48-3-1-33914811141519-2416
Tax %-0%4%58%-10%23%30%-39%1%17%24%17%-6%16%
Net Profit-48-3-2-30791211121116-2314
EPS in Rs-17.47-1.25-0.80-10.842.583.003.713.543.753.524.96-6.794.07
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Jun 2026
58.59%Promoter
Promoters58.59%0.30
FIIs2.19%0.21
DIIs1.92%0.99
Public37.30%0.48
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,837.3034.904,40,8300.87%2,901+5.95%15,300+10.46%20.53%
Divi's Lab.₹9,375.0083.542,48,8770.32%902+65.50%3,080+27.80%21.97%
Torrent Pharma.₹4,840.0082.511,84,0980.79%566+5.79%4,921+54.85%15.19%
Zydus Lifesci.₹1,160.0023.771,15,7100.09%990−35.09%8,017+21.96%21.14%
Cipla₹1,394.5031.481,12,6560.93%786−39.19%7,119+2.33%15.49%
Laurus Labs₹1,954.0096.561,05,5770.10%362+125.49%2,026+29.10%17.76%
Aurobindo Pharma₹1,734.0026.3999,7710.23%1,032+28.11%9,150+16.30%12.86%
Bajaj Healthcare₹330.5519.771,1130.45%14+14.13%166+11.28%11.46%
Median: 158 Co.₹433.9034.562,2050.08%13+29.57%164+18.57%14.96%

Filings

Annual reports15
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016Annual Report 2015Annual Report 2014Annual Report 2013Annual Report 2012
Concall transcripts7
TranscriptJul 2026RECJul 2026PPTDec 2025PPTOct 2025PPTJul 2025PPTJun 2022PPTAug 2020
Credit ratings6
Rating update 6 AugfitchRating update 15 May 2025fitchRating update 28 Feb 2024crisilRating update 28 Aug 2023crisilRating update 7 Jul 2023crisilRating update 18 Nov 2022fitch
Announcements5
Corporate Action-Record Date For Payment Of Final Dividend 3 SepAnnouncement under Regulation 30 (LODR)-Newspaper Publication 30 Aug - Intimation for newspaper publication- Dispatch of Notice of 33rd Annual General Meeting and Annual Report for the financial year 2025-26Shareholders Meeting- Dispatch Of Inland Letters To Shareholders 29 AugBusiness Responsibility and Sustainability Reporting (BRSR) 29 Aug - Bajaj Healthcare filed its FY 2025-26 BRSR as part of the annual report.Reg. 34 (1) Annual Report. 29 Aug